AAIPharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAAIPharma

AAIPharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Azasan	Azathioprine	1999-06-07		Ulcerative colitis , Rheumatoid arthritis , Multiple sclerosis , Crohn disease , Thrombocytopenic purpura idiopathic , Systemic lupus erythematosus , Graft rejection
Darvocet	Acetaminophen, Propoxyphene	1982-01-01	2025-2039	Pain , Fever , Cough , Postoperative pain , Obstructive lung diseases , Headache , Fatigue , Apnea , Rheumatoid arthritis , Inflammation , Osteoarthritis , Rheumatic fever , Gout , Juvenile arthritis , Menorrhagia , Ankylosing spondylitis , Bursitis , Dysmenorrhea , Premenstrual syndrome , Sinusitis , Asthma , Common cold , Allergic rhinitis perennial , Urticaria , Angioedema
Darvon-n	Propoxyphene napsylate	1982-01-01		Pain , Fever , Rheumatoid arthritis , Inflammation , Osteoarthritis , Rheumatic fever , Gout
Darvon-n w/ asa	Aspirin, Propoxyphene napsylate	1982-01-01	2023-2033	Myocardial infarction, Acute coronary syndrome, Rheumatoid arthritis, Pain, Fever, Inflammation, Osteoarthritis, Rheumatic fever, Gout, Headache, Fatigue, Apnea, Myositis, Muscle cramp, Spasm, Tetanus, Muscle rigidity, Muscle spasticity, Cough, Anxiety disorders, Gastroesophageal reflux, Helicobacter infections, Stomach ulcer, Duodenal ulcer, Zollinger-ellison syndrome, Esophagitis, Heartburn, Postoperative pain, Hypercholesterolemia, Coronary artery disease, Hypertriglyceridemia, Hyperlipoproteinemias, Obstructive lung diseases
Ketoconazole	Ketoconazole	1999-07-27		Mycoses, Oral candidiasis, Vulvovaginal candidiasis, Seborrheic dermatitis, Cushing syndrome, Tinea pedis, Coccidioidomycosis, Tinea versicolor, Blastomycosis, Histoplasmosis, Cutaneous candidiasis, Leishmaniasis, Acanthamoeba keratitis, Chronic mucocutaneous candidiasis, Paracoccidioidomycosis

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use